International Development Grant

COVID-19 Vaccine Delivery and Health System Strengthening in Africa

Project Number: CA-3-P011860002

Status: Terminating

Country/Region:

Nigeria 0.90%
Mozambique 16.10%
Cameroon 16.00%
Senegal 5.44%
Côte d'Ivoire 4.90%
Malawi 16.10%
Congo
Democratic Republic 3.10%
Ghana 16.10%
Tanzania 0.76%
Gambia 11.90%

Regional Focus:

Africa 8.7%

Maximum Contribution: $27,000,000.00

Start Date: December 23, 2022

End Date: December 31, 2024

Duration: 2.0 years

Project Description

This project aims to increase equitable access to COVID-19 vaccines particularly among priority groups and vulnerable populations. It also seeks to reinforce health systems through strengthened vaccine delivery community outreach data systems and the delivery of gender-equitable immunization and primary health care in seven target countries in Africa. The project also supports emergency response to the mpox Public Health Emergency of International Concern (PHEIC) in the Democratic of the Congo (DRC). Project activities include: (1) providing technical support for the implementation and monitoring of vaccination programmes particularly gender-responsive components; (2) developing vaccination strategies and plans with gender-responsive interventions; and (3) deploying mobile teams to vaccinate priority groups.

Expected Results

The expected outcomes for this project include: (1) increased COVID-19 vaccination rates among high-priority groups in seven countries. (2) strengthened health systems in seven countries to successfully distribute and deliver COVID-19 vaccines; and (3) developed gender-responsive immunization strategies.

Progress & Results Achieved

Results achieved at the end of the project (December 2024) include: (1) increased COVID-19 vaccination coverage for the primary series from 28.1% in February 2023 to 33.1% in target countries; (2) developed microplanning at sub-national levels and integrated COVID-19 into other routine services including clinics for patients living with human immunodeficiency virus tuberculosis cancer diabetes and cardiovascular diseases; (3) vaccinated an additional 29 million individuals with at least 1 COVID-19 dose. 27 million of them completed the primary series using gender-responsive strategies; and (4) facilitated training on disease surveillance and clinical management for 160 health staff and helped to enhance surveillance and data systems. This enabled contact tracing rates for monkeypox in the DRC to rise from 60% to 83%.

Key Information

Executing Agency:
WHO - World Health Organization

Reporting Organization:
Global Affairs Canada

Program:
YFMInternaAssistPartnershp&Programing Br

Last Modified:
September 19, 2025

Development Classifications

DAC Sector:

COVID-19 control 100%

Aid Type: Contributions to specific-purpose programmes and funds managed by implementing partners

Collaboration: Bilateral

Finance Type: Aid grant excluding debt reorganisation

Selection Mechanism:
Department-Initiated

Policy Markers
Level 1 Gender equality
Level 1 Nutrition
Major Funding (>$1M)
Budget Breakdown
2022-04-01 to 2023-03-31 $27,000,000 CAD
Geographic Information
000
Project Number: CA-3-P011860002